RWJ Health Connect | Patient PortalGo
  • 1-888-MD-RWJUH
  • YouTube

Breast Cancer Trials

A011202

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy.


NSABP B51

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy.


S1207/ e3

Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

This randomized phase III trial studies how well giving hormone therapy together with or without everolimus work in treating patients with breast cancer.


A011104/ACRIN 6694

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

The purpose of this study is to test whether patients undergoing a breast MRI (magnetic resonance imaging) before breast surgery will have better results after the surgery.


E2112

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

Endocrine therapy using exemestane may fight breast cancer by lowering the amount of estrogen the body makes. Entinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether exemestane is more effective with or without entinostat in treating breast cancer.


NRG BR003

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer.


CINJOG 040807

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women with Breast Cancer: A Phase II Trial.


A011401

Breast Cancer WEight Loss Study (BWEL Study)

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer.


For more information, please call Siby Varughese, RN, MA, Research Manager at (908) 685-2481